AGA has been a leader in performance measurement since 2006 and has developed measures for several digestive health conditions and clinical topics including: colorectal cancer screening and surveillance (CRC), gastroesophageal reflux disease (GERD), hepatitis C (HCV) and other liver diseases, and inflammatory bowel disease (IBD).
The AGA Institute Quality Measures Committee provides clinical and methodological expertise and oversight for the development, specification, maintenance and testing of AGA's performance measures.
2017 AGA Performance Measures
Colorectal Cancer Screening and Surveillance
Hepatitis C / Liver Diseases